---
title: "steps contraception"
year: 2024
month: 01
journal: "American Family Physician"
volume: "109-110"
issue: "01"
pages: ""
doi: ""
pmid: ""
source: "PDF Extraction"
pdf_available: true
original_pdf: "2024-01-steps-contraception.pdf"
extracted_date: "2025-08-10"
keywords: []
evidence_level: ""
clinical_significance: ""
---

# steps contraception

                                                                      STEPS
                                                               New Drug Reviews

 Norgestrel 0.075 mg (Opill) for Contraception
     John Torro, MD, and Azmina Bhayani, MD, MPH, Lawrence Family Medicine Residency, Lawrence, Massachusetts


Norgestrel 0.075 mg (Opill) is a once-daily
progestin-only oral contraceptive. It is labeled  Drug                                 Dosage                Dose form               Cost of full course
for use as an over-the-counter medication to
                                                  Norgestrel                          0.075 mg orally        0.075-mg tablet         Price not yet avail-
reduce the likelihood of pregnancy.1
                                                  (Opill)                             once daily                                     able
   The terms woman and women may be used
in this article to reflect original study popu-
lations of cisgender females, but the research
may be extended to all people who could become pregnant.                           Norgestrel is not indicated for use as contraception in pre-
                                                                                  menarchal women, postmenopausal women, or in men.1
Safety
When used as directed, norgestrel is safe for most women                          Tolerability
with reproductive potential. It should not be used in people                      Up to 48% of patients may experience unscheduled uter-
who have or have had breast cancer because norgestrel may                         ine bleeding. Common adverse effects, including nausea,
stimulate breast cancer cell growth by activating the estro-                      breast tenderness, and headaches, occur in 15% to 35% of
gen receptor.2 It is unclear whether oral use of norgestrel for                   patients taking norgestrel.5 About 17% of patients will dis-
contraception can increase lifetime risk of breast cancer in                      continue norgestrel due to adverse effects;​about two-thirds
women.3 Norgestrel should not be used by women who have                           of these patients report irregular bleeding as the cause for
undiagnosed abnormal uterine bleeding or in women with                            discontinuation.4
benign or malignant liver tumors.4
   Norgestrel should not be used during pregnancy, although                       Effectiveness
inadvertent use in pregnancy has not been shown to harm                           Daily norgestrel is effective in preventing pregnancy. Based
a developing fetus.4 The risk of ectopic pregnancy is higher                      on early studies, when norgestrel is used perfectly, the
in women taking norgestrel than in those not taking con-                          effectiveness rate is as high as 98% (i.e., 2 in 100 women
traceptives.4 Norgestrel is regarded as safe to take during                       will become pregnant over one year of use).6 Perfect use
breastfeeding, although small amounts of progestin may                            includes taking one tablet daily, at the same time each day,
pass through breast milk.4 Taking norgestrel increases the                        and without any breaks between 28-day packs. Perfect use
risk of symptomatic ovarian cysts, hepatic neoplasia, and                         also includes using a backup birth control method, such as
liver dysfunction.4                                                               condoms, if a dose is missed or delayed by more than three
   There is a theoretical concern that hepatic enzyme–                            hours after the usual scheduled dose. Typical use effective-
inducing medications, including St. John’s wort, HIV                              ness is lower, estimated to be 91% to 93%. This rate is similar
medications (e.g., efavirenz), and certain antiepileptic med-                     to that of prescription-only contraceptive pills (93%; both
ications, may decrease the effectiveness of norgestrel. If                        progestin-only and combined estrogen-progesterone pills).
prescribing an enzyme inducer, physicians should ensure                           Norgestrel is significantly more effective than other non-
that patients use an alternative form of contraception                            prescription methods, which have a use effectiveness rate
concurrently.1                                                                    of 72% to 86%.7 The data are insufficient regarding whether
                                                                                             hormonal contraception is less effective in people
                                                                                             who are overweight or obese.1
  STEPS new drug reviews cover Safety, Tolerability, Effectiveness, Price,
  and Simplicity. Each independent review is provided by authors who
                                                                                                Price
  have no financial association with the drug manufacturer.
  This series is coordinated by Allen F. Shaughnessy, PharmD, assistant
                                                                                                Although nonprescription norgestrel has been
  medical editor.                                                                               approved by the U.S. Food and Drug Admin-
  A collection of STEPS published in AFP is available at https://​w ww.aafp.                    istration, it is not yet available in pharmacies
  org/afp/steps.                                                                                and prices are unknown. Currently, there is no
  Author disclosure:​No relevant financial relationships.                                       requirement for insurance companies to reim-
                                                                                                burse the cost of this medication.

90 American
Downloaded     Family
            from        Physician
                 the American   Family Physician website at www.aafp.org/afp.           © 2024 American AcademyVolume
                                                                                 Copyright
                                                                   www.aafp.org/afp                                     of Family Physicians.
                                                                                                                                109, NumberFor1 theJanuary
                                                                                                                                                ◆    private, non-
                                                                                                                                                              2024
commercial use of one individual user of the website. All other rights reserved. Contact copyrights@aafp.org for copyright questions and/or permission requests.
                                                            STEPS


           Simplicity                                             are taking norgestrel for birth control before pre-
           Norgestrel is taken once daily. Each dose should       scribing any agents that decrease its effectiveness,
           be taken no more than three hours before or after      such as hepatic enzyme inducers.
           the time the pill was taken on the previous day
                                                                  Address correspondence to John Torro, MD, at john.
           (i.e., between 21 and 27 hours after the previous      torro@​glfhc.org. Reprints are not available from the
           dose).1 If a dose of norgestrel is taken more than     author.
           three hours late or is missed, another dose should
           be taken immediately, then normal once-daily           Author disclosure:​No relevant financial relationships.
           dosing should be resumed. An alternative form          References
           of contraception, such as a condom, should be
                                                                   1. U.S. Food and Drug Administration. Opill (0.075mg
           used during sexual intercourse for two days after          oral norgestrel tablet) information. Accessed Octo-
           a missed or delayed dose to prevent pregnancy.1            ber 29, 2023. https://​w ww.fda.gov/drugs/postmarket-
              When switching from another birth control               d r u g - s a fe t y - i n fo r m a t i o n - p a t i e n t s - a n d - p rov i d e r s /
                                                                      opill-0075mg-oral-norgestrel-tablet-information
           method to norgestrel, the first dose should be         2. Catherino WH, Jeng MH, Jordan VC. Norgestrel and
           taken the day after the previous method is discon-        gestodene stimulate breast cancer cell growth through
           tinued and an alternative form of contraception,          an oestrogen receptor mediated mechanism. Br J Cancer.
                                                                     1993;​67(5):​945-952.
           such as a condom, should be used for the follow-
                                                                  3. The American College of Obstetricians and Gyne-
           ing two days to prevent pregnancy.1                       cologists. Hormonal contraception and risk of breast
                                                                     cancer. Practice advisory. January 2018. Accessed
           Bottom Line                                               October 30, 2023. https://​w ww.acog.org/clinical/
                                                                     clinical-guidance/practice-advisory/articles/2018/01/
           Norgestrel is an effective contraceptive option           hormonal-contraception-and-risk-of-breast-cancer
           in women who have contraindications to com-            4. U.S. Food and Drug Administration Data Access. Opill tab-
           bined estrogen-progesterone treatment. Because            lets. Accessed October 29, 2023. https://​w ww.accessdata.
           norgestrel will be available without a prescrip-          fda.gov/drugsatfda_docs/label/2017/017031s035s036lbl.
                                                                     pdf
           tion, it is a reasonable option for women unable       5. Apelo R, Veloso I. Clinical experience with microdose d-
           to access a medical prescription for birth control.       norgestrel as an oral contraceptive. Fertil Steril. 1973;​24(3):​
           Patients who are taking norgestrel for contracep-         191-197.
           tion should be counseled about taking concurrent       6. Glasier A, Sober S, Gasloli R, et al. A review of the effec-
                                                                     tiveness of a progestogen-only pill containing norgestrel
           medications or supplements that may decrease its          75 µg/day. Contraception. 2022;​105:​1-6.
           effectiveness.                                          7. KM Murray. Decisional memorandum. New drug applica-
              Because norgestrel is an over-the-counter med-          tion 17031 supplement 41. Application for full prescription-
           ication, its use may not be reflected in a patient’s       to-nonprescription switch of norgestrel tablets 0.075 mg.
                                                                      U.S. Food and Drug Administration data access. Accessed
           official health record. Physicians should ask their        October 30, 2023. https://​w ww.accessdata.fda.gov/
           female patients of childbearing potential if they          drugsatfda_docs/nda/2023/017031Orig1s041SumR.pdf ■




January 2024 ◆ Volume 109, Number 1                  www.aafp.org/afp                                                      American Family Physician 91
